SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. Pneumoniae, and A. Baumannii.

Mardirossian, M; Sola, R; Beckert, B; Collis, DWP; Di Stasi, A; Armas, F; Hilpert, K; Wilson, DN; Scocchi, M (2019) Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. Pneumoniae, and A. Baumannii. ChemMedChem, 14 (24). pp. 2025-2033. ISSN 1860-7187 https://doi.org/10.1002/cmdc.201900465
SGUL Authors: Hilpert, Kai

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Proline-rich antimicrobial peptides (PrAMPs) are promising agents to combat multi-drug resistant pathogens due to a high antimicrobial activity, yet low cytotoxicity. A library of derivatives of the PrAMP Bac5(1-17) was synthesized and screened to identify which residues are relevant for its activity. In this way, we discovered that two central motifs -PIRXP- cannot be modified, while residues at N- and C- termini tolerated some variations. We found five Bac5(1-17) derivatives bearing 1-5 substitutions, with an increased number of arginine and/or tryptophan residues, exhibiting improved antimicrobial activity and broader spectrum of activity while retaining low cytotoxicity toward eukaryotic cells. Transcription/translation and bacterial membrane permeabilization assays showed that these new derivatives still retained the ability to strongly inhibit bacterial protein synthesis, but also acquired permeabilizing activity to different degrees. These new Bac5(1-17) derivatives therefore show a dual mode of action which could hinder the selection of bacterial resistance against these molecules.

Item Type: Article
Additional Information: © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Antibiotics, membrane permeabilization, proline-rich peptide, protein synthesis inhibition, solid-phase synthesis, Antibiotics, membrane permeabilization, proline-rich peptide, protein synthesis inhibition, solid-phase synthesis, antibiotics, membrane permeabilization, proline-rich peptide, protein synthesis inhibition, solid-phase synthesis, 0304 Medicinal and Biomolecular Chemistry, 0305 Organic Chemistry, 1115 Pharmacology and Pharmaceutical Sciences, Medicinal & Biomolecular Chemistry
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: ChemMedChem
ISSN: 1860-7187
Language: eng
Dates:
DateEvent
17 December 2019Published
14 November 2019Published Online
31 October 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDUniversity of TriesteUNSPECIFIED
UNSPECIFIED"Made in Trieste" by Area Science Park (Trieste)UNSPECIFIED
UNSPECIFIEDInstitute of Infection and ImmunityUNSPECIFIED
DLR01Kl1820Deutsche Zentrum für Luft- und RaumfahrtUNSPECIFIED
PubMed ID: 31692278
Web of Science ID: WOS:000496281800001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111369
Publisher's version: https://doi.org/10.1002/cmdc.201900465

Actions (login required)

Edit Item Edit Item